Diagnostic and Support Services
- Imaging Services
- Laboratories
- Pharmacy
- Remote Patient Monitoring
- Private Duty Home Care
- Primary Care
- Family Medicine
- Internal Medicine
- Pediatrics
Specialty Care
- Bleeding and Clotting Disorders
- Endocrinology
- Gastroenterology
- Genetics
- Heart and Vascular
- Cardiology
- Vascular Imaging and Surgery
- Hematology-Oncology
- Infectious Disease
- Neurology and Ophthalmology
- ALS Clinic
- Comprehensive Headache and Facial Pain Center
- Muscular Dystrophy Clinic
- Myasthenia Gravis Clinic
- Neuro-Endovascular Surgery | Interventional Neurology
- Peripheral Neuropathy Clinic
- Pediatric Specialty
- Adolescent & Young Adult Oncology
- Pediatric Hematology & Oncology
- Pediatric Infectious Disease
- Occupational and Environmental Medicine
- Osteopathic Manipulative Medicine
- Physical Medicine and Rehabilitation
- Physical & Occupational Therapy
- Psychiatry
- Subspecialty Care | Adult & Pediatric
- Allergy and Immunology
- Comprehensive Bronchopulmonary Dysplasia Center
- Cystic Fibrosis Center
- Pediatric Pulmonology
- Pulmonary Function Laboratory
- Sickle Cell Lifespan
FAQ about the Michigan Controlled Substance Laws
Download this content as a pdf file
Why was this law created?
To counteract the trend of opioid overdose deaths and the opioid epidemic. It’s actually a set of laws. According to the Michigan Department of Health and Human Services from 1999 to 2016, the total number of overdose deaths involving any type of opioid increased more than 17 times in Michigan, from 99 to 1,699.
What is a controlled substance?
Medications are often an integral part of treatment of conditions and diseases. Some medications’ use also may be closely monitored by the state and federal government because of their increased risk of abuse, addiction and dependence. Examples are: Vicodin, Ritalin, Testoterone, and Ambien.
What is a schedule II-V drug?
Controlled substances are categorized into schedules. Three criteria determine a drug’s schedule: How accepted it is for medical use in treatment in the United States, the relative potential for abuse and the likelihood for dependence if abused.
What is MAPS?
The Michigan Automated Prescription System is Michigan’s prescription monitoring program. MAPS is used to track controlled substances, schedules II-V drugs. In Michigan, anytime you receive a schedule II-V drug, it is entered into the MAPS system.
What will education consist of?
For patients, we must discuss the risks of addiction and overdose with both the patient and patient’s parent or legal guardian if the patient is a minor; the increased risk of addiction for people suffering from mental and substance abuse disorders; the prescribed drug’s interactions, and side effects. We let you know how to dispose of any unused or expired controlled substances safely, the consequences of giving your medication to others, and the effects of using controlled substances on pregnancies.
Who will provide the education?
Education can be performed by any licensed healthcare professional. In our clinics, your education will be conducted by a physician; an advanced practice provider such as: a nurse practitioner or a physician assistant; or a nurse.
What are the Michigan Laws?
We’ve summarized the laws and only included the portions that apply to your care at our outpatient clinics.
Public Act 246
- Starting June 1, 2018, a prescriber or licensed health professional must provide education on the risk of addiction, diversion consequences of opioids, how to properly dispose of unwanted opioids and the danger to a fetus, if pregnant or of child-bearing age, before prescribing an opioid to a patient.
- Starting June 1, 2018, consent and signature before patients receive their first prescription of a controlled substance containing an opioid is required.
Public Act 247: Beginning March 31, 2018, if a prescriber provides a controlled substance, the prescriber shall provide follow-up care to the patient (or refer to someone nearby who is able) to monitor the efficacy of the use of the controlled substance as a treatment of the patient’s medical condition.
Public Act 248 & 249: Starting June 1, 2018, a licensed prescriber dispensing controlled substances to a patient in a quantity that exceeds a 3-day supply, must obtain and review a MAPS report concerning that patient.
Public Act 251: Beginning July 1, 2018, if a prescriber is treating a patient for acute pain, the prescriber cannot prescribe the patient more than a 7-day supply of an opioid within a 7-day period.